ClinicalTrials.govpublic full text
Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
metastatic castration resistant prostate cancer (mcrpc), metastatic castration resistant prostate cancer, thorium-227, targeted alpha therapy,psma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 896885
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.